Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""PYRIDINES"" wg kryterium: Temat


Tytuł:
New 2-Chloroimidazo[1,2-a]pyridine induced Schiff bases: Synthesis, characterization, antimicrobial and A-498 and A-549 anticancer activity, molecular modeling, in-silico pharmacokinetics, and DFT studies
Autorzy:
Shailesh S. Gurav
Krishnakant T. Waghmode
Shweta N. Dandekar
Siddheshwar D. Jadhav
Onkar A. Lotlikar
Seema R. Jadhav
Suraj N. Mali
Jayashri G. Naphade
Pokaż więcej
Temat:
2-Chloroimidazo[1,2-a]pyridines
Schiff's bases
Anti-lung and anti-kidney cancer activity
DFT study
ADME
Molecular docking
Physics
QC1-999
Chemistry
QD1-999
Źródło:
Chemical Physics Impact, Vol 8, Iss , Pp 100494- (2024)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S2667022424000380; https://doaj.org/toc/2667-0224
Dostęp URL:
https://doaj.org/article/4517592830f14acca7e958b64aa4d29e  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Synthesis of imidazo[1,2-a]pyridine derivatives and Zolimidine via a novel zinc/iodine-catalyzed Ortoleva-King type protocol
Autorzy:
Mohan Neetha
Elsa Biya
Gopinathan Anilkumar
Pokaż więcej
Temat:
Imidazo[1,2-a]pyridines
Ortoleva-King reaction
Nano zinc oxide
2-Aminopyridines
Zolimidine
Chemistry
QD1-999
Źródło:
Results in Chemistry, Vol 6, Iss , Pp 101070- (2023)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S2211715623003090; https://doaj.org/toc/2211-7156
Dostęp URL:
https://doaj.org/article/cade9081a79d437e851b7c9b15b36e18  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Autorzy:
Cannon CP; Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. />Curtis SP
FitzGerald GA
Krum H
Kaur A
Bolognese JA
Reicin AS
Bombardier C
Weinblatt ME
van der Heijde D
Erdmann E
Laine L
Pokaż więcej
Corporate Authors:
MEDAL Steering Committee
Źródło:
Lancet (London, England) [Lancet] 2006 Nov 18; Vol. 368 (9549), pp. 1771-81.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Cyclooxygenase 2 Inhibitors/*therapeutic use
Diclofenac/*therapeutic use
Osteoarthritis/*drug therapy
Pyridines/*therapeutic use
Sulfones/*therapeutic use
Aged ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Cardiovascular Diseases/chemically induced ; Cyclooxygenase 2 Inhibitors/adverse effects ; Diclofenac/adverse effects ; Etoricoxib ; Female ; Humans ; Male ; Middle Aged ; Multicenter Studies as Topic ; Pyridines/adverse effects ; Randomized Controlled Trials as Topic ; Sulfones/adverse effects
Czasopismo naukowe
Tytuł:
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials.
Autorzy:
Hicks CB; Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC 27710, USA. />Cahn P
Cooper DA
Walmsley SL
Katlama C
Clotet B
Lazzarin A
Johnson MA
Neubacher D
Mayers D
Valdez H
Pokaż więcej
Corporate Authors:
RESIST investigator group
Źródło:
Lancet (London, England) [Lancet] 2006 Aug 05; Vol. 368 (9534), pp. 466-75.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections/*drug therapy
HIV Protease Inhibitors/*therapeutic use
HIV-1/*genetics
Pyridines/*therapeutic use
Pyrones/*therapeutic use
Ritonavir/*therapeutic use
Adult ; Drug Resistance, Viral/genetics ; Drug Therapy, Combination ; Enfuvirtide ; Female ; HIV Envelope Protein gp41/therapeutic use ; HIV Fusion Inhibitors/therapeutic use ; HIV Protease Inhibitors/administration & dosage ; Humans ; Logistic Models ; Male ; Multicenter Studies as Topic ; Peptide Fragments/therapeutic use ; Pyridines/administration & dosage ; Pyrones/administration & dosage ; Randomized Controlled Trials as Topic ; Ritonavir/administration & dosage ; Sulfonamides ; Time Factors ; Treatment Failure ; Viral Load
Czasopismo naukowe
Tytuł:
Learning from the cerivastatin experience.
Autorzy:
Farmer JA; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2001 Oct 27; Vol. 358 (9291), pp. 1383-5.
Typ publikacji:
Journal Article
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*adverse effects
Myositis/*chemically induced
Pyridines/*adverse effects
Rhabdomyolysis/*chemically induced
Animals ; Clinical Trials as Topic ; Humans ; Mice ; Pyridines/metabolism
Czasopismo naukowe
Tytuł:
A pilot safety trial of prolonged (48 h) infusion of the dual endothelin-receptor antagonist tezosentan in patients with advanced heart failure.
Autorzy:
Torre-Amione G; Winter Center for Heart Failure Research and the Eugene and Judith Campbell Laboratories for Cardiac Transplantation Research, Methodist Hospital and Houston VA Medical Center, Baylor College of Medicine, Houston, TX 77030, USA. />Durand JB
Nagueh S
Vooletich MT
Kobrin I
Pratt C
Pokaż więcej
Źródło:
Chest [Chest] 2001 Aug; Vol. 120 (2), pp. 460-6.
Typ publikacji:
Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Endothelin Receptor Antagonists*
Heart Failure/*drug therapy
Pyridines/*administration & dosage
Tetrazoles/*administration & dosage
Acute Disease ; Aged ; Dobutamine/administration & dosage ; Double-Blind Method ; Drug Tolerance ; Echocardiography, Doppler ; Female ; Hemodynamics/drug effects ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Pilot Projects ; Pyridines/adverse effects ; Safety ; Tetrazoles/adverse effects
Czasopismo naukowe
Tytuł:
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
Autorzy:
Rouleau JL; Division of Cardiology, Toronto General Hospital, University of Toronto, ON, Canada. />Pfeffer MA
Stewart DJ
Isaac D
Sestier F
Kerut EK
Porter CB
Proulx G
Qian C
Block AJ
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2000 Aug 19; Vol. 356 (9230), pp. 615-20.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Exercise Tolerance/*drug effects
Heart Failure/*drug therapy
Lisinopril/*therapeutic use
Neprilysin/*antagonists & inhibitors
Pyridines/*therapeutic use
Thiazepines/*therapeutic use
Angiotensin II/blood ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Atrial Natriuretic Factor/blood ; Double-Blind Method ; Endothelin-1/blood ; Female ; Heart Failure/blood ; Heart Failure/diagnostic imaging ; Heart Failure/mortality ; Humans ; Lisinopril/adverse effects ; Male ; Middle Aged ; Norepinephrine/blood ; Prospective Studies ; Pyridines/adverse effects ; Radionuclide Ventriculography ; Severity of Illness Index ; Survival Rate ; Thiazepines/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Vasopeptidase inhibition and angio-oedema.
Autorzy:
Messerli FH; Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA 70121, USA.
Nussberger J
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2000 Aug 19; Vol. 356 (9230), pp. 608-9.
Typ publikacji:
Comment; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angioedema/*chemically induced
Angiotensin-Converting Enzyme Inhibitors/*adverse effects
Heart Failure/*drug therapy
Lisinopril/*adverse effects
Neprilysin/*antagonists & inhibitors
Pyridines/*adverse effects
Thiazepines/*adverse effects
Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Heart Failure/complications ; Humans ; Lisinopril/therapeutic use ; Odds Ratio ; Prognosis ; Pyridines/therapeutic use ; Risk Assessment ; Thiazepines/therapeutic use
Czasopismo naukowe
Tytuł:
Test for catatonia with zolpidem.
Autorzy:
Thomas P
Rascle C
Mastain B
Maron M
Vaiva G
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 1997 Mar 08; Vol. 349 (9053), pp. 702.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Hypnotics and Sedatives*/blood
Hypnotics and Sedatives*/therapeutic use
Pyridines*/blood
Pyridines*/therapeutic use
Catatonia/*diagnosis
Administration, Oral ; Adult ; Alprazolam/therapeutic use ; Catatonia/blood ; Catatonia/drug therapy ; Female ; Humans ; Zolpidem
Raport
Tytuł:
Piperazine-Amberlyst®15-catalysed synthesis of 2-amino-4H-chromenes, chromeno[2,3-b]pyridines and chromeno[2,3-d]pyrimidines
Autorzy:
Giovanna Bosica
Roderick Abdilla
Pokaż więcej
Temat:
2-Amino-4H-chromenes
chromeno[2,3-b]pyridines
chromeno[2,3-d]pyrimidines
Piperazine-Amberlyst® 15
Heterogeneous catalyst
Multicomponent reactions
Chemistry
QD1-999
Źródło:
Tetrahedron Green Chem, Vol 1, Iss , Pp 100011- (2023)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S2773223123000109; https://doaj.org/toc/2773-2231
Dostęp URL:
https://doaj.org/article/41469bdad1cc427ba1498da9330ac4ce  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
From optically pure pyridinium salts to some new dihydro-2H-oxazolo[3,2-a]pyridines
Autorzy:
R.G. Moura
P.R. Batista
L.C. Ducati
J. Gruber
L.F. Yamaguchi
L. Marzorati
Pokaż więcej
Temat:
Chiral Katritzky salts
Oxazolo[3,2a]pyridines
Isoquinuclidine
Chemistry
QD1-999
Źródło:
Results in Chemistry, Vol 5, Iss , Pp 100820- (2023)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S2211715623000590; https://doaj.org/toc/2211-7156
Dostęp URL:
https://doaj.org/article/050fd747b1c94cabad4451818a1ce9ea  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Nickel/iodine-catalyzed synthesis of 2-arylimidazo[1,2-a]pyridines through Ortoleva-King type protocol
Autorzy:
Rose Mary Philip
Thaipparambil Aneeja
Gopinathan Anilkumar
Pokaż więcej
Temat:
2-arylimidazo[1,2-a]pyridines
Iodine
Nickel
Ortoleva-King intermediate
Zolimidine
Chemistry
QD1-999
Źródło:
Results in Chemistry, Vol 5, Iss , Pp 100750- (2023)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S2211715622004696; https://doaj.org/toc/2211-7156
Dostęp URL:
https://doaj.org/article/a9bd4c0259164ea5b6e4578519b1a547  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
A novel manganese/iodine-catalyzed Ortoleva-King type protocol for the synthesis of imidazo[1,2-a]pyridines and Zolimidine
Autorzy:
Thaipparambil Aneeja
Rose Mary Philip
Gopinathan Anilkumar
Pokaż więcej
Temat:
Imidazo[1,2-a]pyridines
Oroleva-King type reaction
Manganese
Iodine
Zolimidine
Chemistry
QD1-999
Źródło:
Results in Chemistry, Vol 4, Iss , Pp 100474- (2022)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S221171562200193X; https://doaj.org/toc/2211-7156
Dostęp URL:
https://doaj.org/article/8d3353e9916c421f878e75dea6ac7fef  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma.
Autorzy:
Hoyle M; Peninsula Medical School, University of Plymouth, Plymouth, UK. />Green C
Thompson-Coon J
Liu Z
Welch K
Moxham T
Stein K
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2010 Jan-Feb; Vol. 13 (1), pp. 55-60. Date of Electronic Publication: 2009 Sep 25.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*economics
Antineoplastic Agents/*therapeutic use
Benzenesulfonates/*economics
Benzenesulfonates/*therapeutic use
Carcinoma, Renal Cell/*drug therapy
Kidney Neoplasms/*drug therapy
Pyridines/*economics
Pyridines/*therapeutic use
Carcinoma, Renal Cell/economics ; Chemotherapy, Adjuvant/economics ; Cost-Benefit Analysis ; Decision Support Techniques ; Disease Progression ; Humans ; Kidney Neoplasms/economics ; Markov Chains ; Models, Statistical ; National Health Programs ; Niacinamide/analogs & derivatives ; Phenylurea Compounds ; Quality-Adjusted Life Years ; Sorafenib ; United Kingdom
Czasopismo naukowe
Tytuł:
S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells.
Autorzy:
Kwon CH; Department of Pathology, Pusan National University Hospital and Pusan National University School of Medicine, Busan 602-739, Korea.
Moon HJ
Park HJ
Choi JH
Park DY
Pokaż więcej
Źródło:
Molecules and cells [Mol Cells] 2013 Mar; Vol. 35 (3), pp. 226-34. Date of Electronic Publication: 2013 Feb 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell Movement*
Calgranulin A/*physiology
Calgranulin B/*physiology
NF-kappa B/*metabolism
Stomach Neoplasms/*metabolism
p38 Mitogen-Activated Protein Kinases/*metabolism
Cell Line, Tumor ; Enzyme Activation ; Humans ; Imidazoles/pharmacology ; MAP Kinase Signaling System ; Matrix Metalloproteinase 12/metabolism ; Matrix Metalloproteinase 2/metabolism ; Phosphorylation ; Protein Processing, Post-Translational ; Pyridines/pharmacology ; Stomach Neoplasms/pathology ; p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies